Sanjeev Vernekar - Publications

Center for Drug Design University of Minnesota, Twin Cities, Minneapolis, MN 

12 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Wang L, Casey MC, Vernekar SKV, Do HT, Sahani RL, Kirby KA, Du H, Hachiya A, Zhang H, Tedbury PR, Xie J, Sarafianos SG, Wang Z. Chemical profiling of HIV-1 capsid-targeting antiviral PF74. European Journal of Medicinal Chemistry. 200: 112427. PMID 32438252 DOI: 10.1016/j.ejmech.2020.112427  0.48
2020 Vernekar SKV, Sahani RL, Casey MC, Kankanala J, Wang L, Kirby KA, Du H, Zhang H, Tedbury PR, Xie J, Sarafianos SG, Wang Z. Toward Structurally Novel and Metabolically Stable HIV-1 Capsid-Targeting Small Molecules. Viruses. 12. PMID 32316297 DOI: 10.3390/v12040452  0.48
2017 Vernekar SKV, Tang J, Wu B, Huber AD, Casey MC, Myshakina NS, Wilson DJ, Kankanala J, Kirby KA, Parniak MA, Sarafianos SG, Wang Z. Double-winged 3-Hydroxypyrimidine-2,4-diones: Potent and Selective Inhibition against HIV-1 RNase H with Significant Antiviral Activity. Journal of Medicinal Chemistry. PMID 28525279 DOI: 10.1021/acs.jmedchem.7b00440  0.48
2017 Tang J, Vernekar SK, Chen YL, Miller L, Huber AD, Myshakina N, Sarafianos SG, Parniak MA, Wang Z. Synthesis, biological evaluation and molecular modeling of 2-Hydroxyisoquinoline-1,3-dione analogues as inhibitors of HIV reverse transcriptase associated ribonuclease H and polymerase. European Journal of Medicinal Chemistry. 133: 85-96. PMID 28384548 DOI: 10.1016/j.ejmech.2017.03.059  0.48
2015 Vernekar SK, Qiu L, Zhang J, Kankanala J, Li H, Geraghty RJ, Wang Z. 5'-Silylated 3'-1,2,3-triazolyl Thymidine Analogues as Inhibitors of West Nile Virus and Dengue Virus. Journal of Medicinal Chemistry. 58: 4016-28. PMID 25909386 DOI: 10.1021/acs.jmedchem.5b00327  0.48
2015 Vernekar SK, Liu Z, Nagy E, Miller L, Kirby KA, Wilson DJ, Kankanala J, Sarafianos SG, Parniak MA, Wang Z. Design, synthesis, biochemical, and antiviral evaluations of C6 benzyl and C6 biarylmethyl substituted 2-hydroxylisoquinoline-1,3-diones: dual inhibition against HIV reverse transcriptase-associated RNase H and polymerase with antiviral activities. Journal of Medicinal Chemistry. 58: 651-64. PMID 25522204 DOI: 10.1021/jm501132s  0.48
2014 Vernekar SKV, Qiu L, Zacharias J, Geraghty RJ, Wang Z. Synthesis and antiviral evaluation of 4′-(1,2,3-triazol-1-yl) thymidines Medchemcomm. 5: 603-608. DOI: 10.1039/c4md00039k  0.48
2013 Sirivolu VR, Vernekar SK, Ilina T, Myshakina NS, Parniak MA, Wang Z. Clicking 3'-azidothymidine into novel potent inhibitors of human immunodeficiency virus. Journal of Medicinal Chemistry. 56: 8765-80. PMID 24102161 DOI: 10.1021/jm401232v  0.48
2012 Sirivolu VR, Vernekar SK, Marchand C, Naumova A, Chergui A, Renaud A, Stephen AG, Chen F, Sham YY, Pommier Y, Wang Z. 5-Arylidenethioxothiazolidinones as inhibitors of tyrosyl-DNA phosphodiesterase I. Journal of Medicinal Chemistry. 55: 8671-84. PMID 23006064 DOI: 10.1021/jm3008773  0.48
2012 Simonin J, Vernekar SK, Thompson AJ, Hothersall JD, Connolly CN, Lummis SC, Lochner M. High-affinity fluorescent ligands for the 5-HT(3) receptor. Bioorganic & Medicinal Chemistry Letters. 22: 1151-5. PMID 22189135 DOI: 10.1016/j.bmcl.2011.11.097  0.48
2010 Vernekar SK, Hallaq HY, Clarkson G, Thompson AJ, Silvestri L, Lummis SC, Lochner M. Toward biophysical probes for the 5-HT3 receptor: structure-activity relationship study of granisetron derivatives. Journal of Medicinal Chemistry. 53: 2324-8. PMID 20146481 DOI: 10.1021/jm901827x  0.48
2008 Vernekar SKV, Kipke P, Redlich H. Syntheses of branched non-1-ynitols by chemoselective addition of (trimethylsilyl)-propargylmagnesium bromide at the anomeric center of side chain halogeno functionalized carbohydrates Journal of Carbohydrate Chemistry. 27: 10-31. DOI: 10.1080/07328300801991278  0.48
Show low-probability matches.